BrainStorm Cell Therapeutics Logo
US10501E2019
A12BXW
BCLI

BrainStorm Cell Therapeutics

Dividend yield TTM
0.00%
€0.00/share
Dividend growth (CAGR 5Y)
-
Next dividend
It is unlikely that any further dividends will be paid.

Upcoming dividends delivered straight to your inbox

Historical dividends

In 2005, BrainStorm Cell Therapeutics has already paid €0.0062 in dividends. The last payout was in June 2005.

Tools for dividend investors

Dividend metrics Metrics

All metrics All
Metric Value
Price
€0.99
Yield
0.00%
Interval
None
CAGR 3Y
-
CAGR 5Y
-
CAGR 10Y
-

All dividend data

BrainStorm Cell Therapeutics has not paid a dividend in the last 3 years. It is therefore likely that no further dividends will be paid.

New dividends delivered straight to your inbox
Ex-dividend date
Payment date
Distribution
YoY
Yield
2005 €0.0062 0.00% 0.11%
05/20/2005 06/15/2005 €0.0062

Frequently asked questions

When was the most recent dividend payment date for BrainStorm Cell Therapeutics?

The most recent payment was made on 06/15/2005.

When did you need to hold BrainStorm Cell Therapeutics in your portfolio to receive the latest dividend?

If you held BrainStorm Cell Therapeutics in your portfolio on 05/20/2005, you received the payout.

When is the next dividend from BrainStorm Cell Therapeutics expected?

As BrainStorm Cell Therapeutics has not paid a dividend in the last 3 years, it is unlikely to pay another dividend.

More dividend stocks

All dividends in the calendar
Name Interval
Yield
CAGR 5Y
General Electric Logo
US3696041033
851144
Y 0.00% -
Garmin Logo
CH0114405324
A1C06B
Q 1.30% 7.52%
Protector Forsikring Logo
NO0010209331
A0MSGT
Q 4.02% -
XYLEM Logo
US98419M1009
A1JMBU
Q 1.48% 9.00%
Scout24 Logo
DE000A12DM80
A12DM8
Y 1.86% 6.22%
Gladstone Land Logo
US3765491010
A1KCL7
M 6.29% 1.14%
ASML Holding NV ADR Logo
USN070592100
A1J85V
Q 0.53% 20.98%
Gilead Sciences Logo
US3755581036
885823
Q 2.18% 3.13%
Exponent Logo
US30214U1025
880114
Q 1.72% 9.75%
RATIONAL Logo
DE0007010803
701080
Y 3.14% 21.35%
🍪

Parqet  uses cookies. Learn more